Early Stage Drug Development Company

We’re a high value-added company that applies photoisomerization conversion technology

Total Assets

Unit:1,000 KRW
Y2019 Y2020 Y2021
3,694,792 4,082,386 4,302,102

Total Liabilities

Unit:1,000 KRW
Y2019 Y2020 Y2021
1,759,318 2,125,968 2,323,913

Equity

Unit:1,000 KRW
Y2019 Y2020 Y2021
1,110,242 1,110,242 1,110,242

Total Equity

Unit:1,000 KRW
Y2019 Y2020 Y2021
1,935,474 1,956,418 1,978,189